169 related articles for article (PubMed ID: 29756166)
1. Dosimetric characterisation of the optically-stimulated luminescence dosimeter in cobalt-60 high dose rate brachytherapy system.
Rejab M; Wong JHD; Jamalludin Z; Jong WL; Malik RA; Wan Ishak WZ; Ung NM
Australas Phys Eng Sci Med; 2018 Jun; 41(2):475-485. PubMed ID: 29756166
[TBL] [Abstract][Full Text] [Related]
2. Development and implementation of a remote audit tool for high dose rate (HDR) Ir-192 brachytherapy using optically stimulated luminescence dosimetry.
Casey KE; Alvarez P; Kry SF; Howell RM; Lawyer A; Followill D
Med Phys; 2013 Nov; 40(11):112102. PubMed ID: 24320455
[TBL] [Abstract][Full Text] [Related]
3. Dosimetric characterization of optically stimulated luminescence dosimeter with therapeutic photon beams for use in clinical radiotherapy measurements.
Ponmalar R; Manickam R; Ganesh KM; Saminathan S; Raman A; Godson HF
J Cancer Res Ther; 2017; 13(2):304-312. PubMed ID: 28643752
[TBL] [Abstract][Full Text] [Related]
4. Monte Carlo study of the relationship between skin dose and optically stimulated luminescence dosimeter dose in Pd-103 permanent breast seed implant brachytherapy.
Nich S; Kirkby C; Villarreal-Barajas JE
Brachytherapy; 2019; 18(3):387-395. PubMed ID: 30792005
[TBL] [Abstract][Full Text] [Related]
5. Changes in optically stimulated luminescent dosimeter (OSLD) dosimetric characteristics with accumulated dose.
Jursinic PA
Med Phys; 2010 Jan; 37(1):132-40. PubMed ID: 20175474
[TBL] [Abstract][Full Text] [Related]
6. In vivo measurements for high dose rate brachytherapy with optically stimulated luminescent dosimeters.
Sharma R; Jursinic PA
Med Phys; 2013 Jul; 40(7):071730. PubMed ID: 23822434
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of an OSLD in the diagnostic energy range.
Al-Senan RM; Hatab MR
Med Phys; 2011 Jul; 38(7):4396-405. PubMed ID: 21859040
[TBL] [Abstract][Full Text] [Related]
8. Characterization of MOSkin detector for in vivo dose verification during Cobalt-60 high dose-rate intracavitary brachytherapy.
Jamalludin Z; Jong WL; Abdul Malik R; Rosenfeld A; Ung NM
Phys Med; 2019 Feb; 58():1-7. PubMed ID: 30824140
[TBL] [Abstract][Full Text] [Related]
9. Validation of OSLD and a treatment planning system for surface dose determination in IMRT treatments.
Zhuang AH; Olch AJ
Med Phys; 2014 Aug; 41(8):081720. PubMed ID: 25086530
[TBL] [Abstract][Full Text] [Related]
10. A disposable OSL dosimeter for in vivo measurement of rectum dose during brachytherapy.
Hayashi H; Kimoto N; Maeda T; Tomita E; Asahara T; Goto S; Kanazawa Y; Shitakubo Y; Sakuragawa K; Ikushima H; Okazaki T; Hashizume T
Med Phys; 2021 Aug; 48(8):4621-4635. PubMed ID: 33760234
[TBL] [Abstract][Full Text] [Related]
11. Chromatic bleaching and fractionation effects on optically stimulated luminescent dosimeter reuse.
Scott H; Alvarez PE; Howell RM; Riegel A; Sun R; Liu K; Kry SF
Med Phys; 2024 Jun; ():. PubMed ID: 38852196
[TBL] [Abstract][Full Text] [Related]
12. Optically stimulated luminescent dosimetry for high dose rate brachytherapy.
Tien CJ; Ebeling R; Hiatt JR; Curran B; Sternick E
Front Oncol; 2012; 2():91. PubMed ID: 22888476
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of optically stimulated luminescence dosimeters in the spread-out Bragg peak region of clinical proton beams.
Kerns JR; Kry SF; Sahoo N
Med Phys; 2012 Apr; 39(4):1854-63. PubMed ID: 22482607
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the nanoDot OSLD dosimeter in CT.
Scarboro SB; Cody D; Alvarez P; Followill D; Court L; Stingo FC; Zhang D; McNitt-Gray M; Kry SF
Med Phys; 2015 Apr; 42(4):1797-807. PubMed ID: 25832070
[TBL] [Abstract][Full Text] [Related]
15. Angular dependence of the response of the nanoDot OSLD system for measurements at depth in clinical megavoltage beams.
Lehmann J; Dunn L; Lye JE; Kenny JW; Alves AD; Cole A; Asena A; Kron T; Williams IM
Med Phys; 2014 Jun; 41(6):061712. PubMed ID: 24877807
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of optically stimulated luminescence dosimeter for exit dose
Ponmalar R; Manickam R; Saminathan S; Ganesh KM; Raman A; Godson HF
J Cancer Res Ther; 2018; 14(6):1341-1349. PubMed ID: 30488854
[TBL] [Abstract][Full Text] [Related]
17. Optically stimulated luminescent dosimeters stable response to dose after repeated bleaching.
Jursinic PA
Med Phys; 2020 Jul; 47(7):3191-3203. PubMed ID: 32297332
[TBL] [Abstract][Full Text] [Related]
18. Measurement of surface dose in an MR-Linac with optically stimulated luminescence dosimeters for IMRT beam geometries.
Lim-Reinders S; Keller BM; Sahgal A; Chugh B; Kim A
Med Phys; 2020 Jul; 47(7):3133-3142. PubMed ID: 32302010
[TBL] [Abstract][Full Text] [Related]
19. Remote auditing of radiotherapy facilities using optically stimulated luminescence dosimeters.
Lye J; Dunn L; Kenny J; Lehmann J; Kron T; Oliver C; Butler D; Alves A; Johnston P; Franich R; Williams I
Med Phys; 2014 Mar; 41(3):032102. PubMed ID: 24593737
[TBL] [Abstract][Full Text] [Related]
20. Comparison of planned and measured rectal dose in-vivo during high dose rate Cobalt-60 brachytherapy of cervical cancer.
Zaman ZK; Ung NM; Malik RA; Ho GF; Phua VC; Jamalludin Z; Baharuldin MT; Ng KH
Phys Med; 2014 Dec; 30(8):980-4. PubMed ID: 25086486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
